We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Development Doesn’t Always Have to Start From Scratch

Article   Jun 05, 2017 | Simon Pearce, Market Segment Manager for Organics, with Thermo Fisher Scientific

 
Drug Development Doesn’t Always Have to Start From Scratch
 
 
 

RELATED ARTICLES

Cell Signaling in Cancer

Article

This article discusses the relationship between cell signaling and cancer, highlights key signaling pathways involved in cancer, and explores how critical mediators of aberrant signaling can be turned into therapeutic targets for cancer.

READ MORE

Discovering Druggable Targets

Article

We recently spoke to Dr Kilian V. M. Huber from the Structural Genomics Consortium & Target Discovery Institute, University of Oxford to find out – ‘What makes a good target?’.

READ MORE

Target Identification & Validation in Drug Discovery

Article

This article highlights the properties of an attractive drug target, outlines the approaches used to identify targets, and discusses the key steps involved in target validation and the benefits and challenges of using siRNA to validate targets.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE